OR09-3 11β-HSD1 Mediates a Partial Suppression of Muscle Atrophy in Chronic Inflammatory Disease in Response to Therapeutic Glucocorticoids

Objective: Therapeutic glucocorticoids (GCs) are routinely used in the treatment of chronic inflammatory disease due to their potent anti-inflammatory effects. Despite their efficacy, chronic exposure to GCs elicits undesirable side effects, including muscle atrophy (1). 11 beta-hydroxysteroid dehyd...

Descripción completa

Detalles Bibliográficos
Autores principales: Webster, Justine, Fenton, Chloe, Raza, Karim, Lavery, Gareth, Langen, Ramon, Hardy, Rowan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Steroid Hormones and Receptors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554818/
http://dx.doi.org/10.1210/js.2019-OR09-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554818/
http://dx.doi.org/10.1210/js.2019-OR09-3

Ejemplares similares